Angela Lamarca: We MUST validate innovate biomarkers in clinical trials

Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on X:

“Last session of the day on Precision Medicine in European Network for the Study of Cholangiocarcinoma (ENS-CCA), Precision-BTC-Network joint meeting in Krakow.

• surgical candidates
• neoadjuvant
• chemoresistance?
• markers for IO
• new markers- circRNAs

We MUST validate innovate biomarkers in clinical trials.”

Source: Angela Lamarca/X